Introduction {#Sec1}
============

Newcastle disease virus (NDV) and infectious bronchitis virus (IBV) are two poultry pathogens causing major economic losses for the poultry industry. These respiratory viruses can co-circulate in Egyptian chicken farms. Newcastle disease (ND) is a contagious disease causing a high mortality rate (70--100%) in avian species. NDV is a negative sense, single-stranded, monopartite RNA virus of the Avian Paramyxovirus type 1 (APMV-1). NDV strains have been categorized according to virulence as lentogenic, mesogenic, and velogenic strains. Velogenic strains are the most virulent, causing respiratory tract lesions as well as sever hemorrhagic lesions in the digestive tract (viscerotropic), and/or neurological signs (neurotropic). The lentogenic strains have low virulence and are common among domestic poultry \[[@CR1], [@CR2]\].

Infectious bronchitis (IB) is an infectious viral disease affecting poultry and induced by a positive-sense single-stranded RNA coronavirus. The disease characterized clinically by respiratory distress and sharp drop in egg production and quality in layers. There have been reports of IBV strains associated with nephritis \[[@CR3]--[@CR5]\].

Rapid identification of these viruses will facilitate control measures implementation and consequently, declines the economic losses. Therefore, portable, accurate, inexpensive, simple, and rapid, on site test is needed for diagnosis on the spot of infection.

Currently, field detection of these viruses depends on clinical manifestations and post-mortem examination. Confirmative laboratory diagnosis can be carried out by virus isolation, haemagglutination inhibition, enzyme-linked immunosorbent assay (ELISA), immunofluorescence techniques and neutralization test \[[@CR1], [@CR2], [@CR4]--[@CR7]\]. Also, reverse transcription-PCR (RT-PCR) and quantitative real time RT-PCR (qRT-PCR) have been reported for molecular detection of these viruses \[[@CR8]--[@CR13]\]. However, the lack of adequate laboratory resources, skilled staff requirement and the time consuming nature of the above mentioned diagnostic methods constitute obstacles to the rapid detection under field condition.

Recombinase polymerase amplification (RPA) is a single-tube isothermal amplification and detection methodology for DNA and has equal sensitivity to real time-polymerase chain reaction. In contrast to PCR, it uses only one constant temperature. The amplification step depends first on a recombinase (UvsX and co-factor UvsY from T4 Enterobacteria phage) binding to specific primers followed by scanning the DNA for the complementary sequence. Once invasion of the strand is maintained by the single strand binding protein (T4 gp32), a primer extension is ensued via a strand displacing DNA polymerase (*Staphylococcus aureus*) \[[@CR14]--[@CR18]\]. Lateral flow immunoassays are currently widely used due to their simplicity, low cost, good specificity, rapid result, electricity-free operation and long shelf life, making them suitable for on-site pathogen detection particularly in developing countries \[[@CR19]\]. RPA combined with lateral flow dipstick (LFD) detection of amplicons has been previously reported for H9 subtype of avian influenza virus detection in Central China and proved to be appropriate for field application \[[@CR20]\].

The aim of our study was developing a field applicable, simple, specific and rapid molecular diagnostic method for ND and IB viruses using recombinase polymerase amplification, combined with nucleic acid lateral flow immunoassays for results visualization.

Materials and methods {#Sec2}
=====================

Template preparation {#Sec3}
--------------------

Synthesized templates of NDV matrix protein (M) gene and IBV nucleoprotein (N) gene were designed according to previously published sequences in GenBank with Accession number AY562988 for NDV and FJ589733 for IBV. The templates were synthesized by Integrated DNA Technologies (IDT), Leuven, Belgium. They were received in lyophilized form (250 ng), centrifuged for 3--5 s at 3000×*g* to ensure the lyophilized material at the bottom of the tube, then resuspended in TE buffer to reach a final concentration of 10 ng/μl (7 × 10^10^ gene copies/μl) before incubated at 50 °C for 20 min and centrifuged. The prepared templates are stored at − 20 °C till use.

Oligonucleotide primers {#Sec4}
-----------------------

The used specific primers can amplify a specific fragment of M gene of NDV (125 bp) and N gene of IBV (131 bp), as described previously \[[@CR10], [@CR21]\]. For the NDV assay, M gene forward primer labeled with DIG while reverse primer labeled with Biotin. For IBV assay, N gene forward primer labeled with FAM and reverse primer conjugated with Biotin. The labeled oligonucleotide primers were obtained from Integrated DNA Technologies (IDT), Leuven, Belgium. These primers were received in lyophilized form and TE buffer was used in resuspension of the primers to obtain a final concentration of 100 μM/μl. Details of modified primers used for the identification of NDV and IBV summarized in Table [1](#Tab1){ref-type="table"}. The primers used in our study were also verified for their cross reactivity with other avian respiratory viruses using NCBI database BLAST search (<http://www.ncbi.nlm.nih.gov>) and there was no cross reactivity observed with avian influenza viruses (H5N1, H5N8 and H9N2), Infectious laryngeotracheitis virus (ILT) and avian reovirus.Table 1Primers used for the identification of NDV and IBV nucleic acids templatesVirusPrimers sequences and tagsTarget geneReferencesNewcastle disease virus (NDV)M + 4100 (5′ **DIG**-AGTGATGTGCTCGGACCTTC-3′)M-4220 (5′ **Biotin**-CCTGAGGAGAGGCATTTGCTA-3′)M gene\[[@CR10]\]Infectious bronchitis virus (IBV)AIBV-fr (5′ **FAM**-ATGCTCAACCTTGTCCCTAGCA-3′)AIBV-as (5′ **Biotin**-TCAAACTGCGGATCATCACGT-3′)N gene\[[@CR21]\]

NDV and IBV RPA amplification conditions {#Sec5}
----------------------------------------

RPA assays were carried out via the twistAmp^®^ Basic kit (TwistDx Limited, Cambridge, UK). Briefly, 2.4 μl of each primer, 29.5 μl of rehydration buffer and 11.2 μl of nuclease free water were added to the lyophilized pellet in the RPA-tubes strip, followed by adding 2.5 μl of 280 mM Mg acetate in each lid. Then, 1 μl of each nucleic acid template was added. The RPA-tubes strip was centrifuged before placed into Axxin T16 isothermal instrument at 38 °C for period of 40 min. Also, the amplification reaction was examined after incubation period of 20 min. A negative control was included in each run. All experiments were performed three times.

Nucleic acid lateral flow (NALF) detection {#Sec6}
------------------------------------------

For visual detection of labeled RPA amplicons, PCRD nucleic acid detector (Abingdon Health Ltd, National Innovation Campus, Sand Hutton, York, UK) was used. This device utilizes antibodies against primer-tags (DIG, FAM, Biotin) and has been designed for lateral flow detection of amplified products (Fig. [1](#Fig1){ref-type="fig"}). The device comprises a sample well, conjugate pad, nitrocellulose membrane and absorbent pad, which are collected together in a plastic container. NALF detection was performed separately for the NDV and IBV assays, using separate devices for each assay. Following RPA reaction, 5 μl of the amplification product was transferred into a 0.5 ml tube and mixed thoroughly with 70 μl of the PCRD extraction buffer and added to the sample well of a PCRD test cassette.Fig. 1Schematic representation of PCRD nucleic acid detector design. At the conjugate pad, the carbon Biotin-conjugated antibodies bind to biotin on one end of the amplicons, and flows towards the test-lines, L1 and L2. L1 is lined with anti-DIG monoclonal antibodies to capture DIG/Biotin labeled amplicons for NDV assay. L2 is lined with anti-FAM monoclonal antibodies to capture FAM/Biotin labeled amplicons for IBV assay. The excess carbon Biotin-conjugated antibodies are captured by anti-mouse antibodies at the control line (C)

Upon sample application, the carbon Biotin-conjugated antibodies were rehydrated and reacted with the tag/Biotin-labeled amplicons in the sample. The first line (L1) consisted of anti-DIG monoclonal antibodies for capturing DIG/Biotin labeled amplicons for the NDV assay. The second line (L2) contains anti-FAM monoclonal antibodies to capture FAM/Biotin labeled amplicons for IBV assay. The excess carbons dots covered with Biotin antibodies flowed pass the two test-lines and were fixed at the control line (C) to ensure that a PCRD test cassette operating correctly. The cassette was kept in a horizontal position, and the results were recorded after 5 min.

The limit of detection (LOD) {#Sec7}
----------------------------

To detect the minimum number of genome copies of NDV and IBV that can be reliably detected by RPA-NALF assays. Tenfold serial dilutions of the gene templates were carried out as follows; 10 ng (10^7^ genome copies), 1 ng (10^6^ genome copies), 0.1 ng (10^5^ genome copies), 0.01 ng (10^4^ genome copies), 0.001 ng (10^3^ genome copies), 0.0001 ng (10^2^ genome copies) and 0.00001 ng (10 genome copies). Amplified RPA amplicons were detected using PCRD nucleic acid detector as described above.

Clinical performance of NDV and IBV RT-RPA-NALF immunoassays {#Sec8}
------------------------------------------------------------

Thirty-six oropharyngeal swabs were collected from 12 Egyptian chicken flocks in Dakahlia Governorate (three samples from each flock) with respiratory manifestations (nasal discharge, conjunctivitis, rales and gasping). A total of 12 pools were created. RNA extracts of the pooled clinical samples were tested for NDV and IBV via RT-RPA-NALF using twistAmp^®^ Basic RT kit (Twist Dx, UK) according to the kit manual and results visualization was done via PCRD test cassettes. Testing of pooled samples in parallel using qRT-PCR was carried out \[[@CR12], [@CR21]\]. Negative and positive controls were used to assess false positive results.

Results {#Sec9}
=======

RPA amplification and detection by NALF {#Sec10}
---------------------------------------

A 75 μl suspension composed of 5 μl of RPA amplicons after incubation for period of 40 min at 38 °C mixed thoroughly with 70 μl of the PCRD extraction buffer was applied to the sample well of PCRD nucleic acid detector. After about 5 min, black lines at test line 1 (L1) and control line (C) in case of NDV assay and two black lines at test line 2 (L2) and control line (C) in case of IBV assay were observed. Negative control included in each run showed only black line at the control line (C) (Fig. [2](#Fig2){ref-type="fig"}). NDV RPA assay showed no cross detection with IBV, and vice versa.Fig. 2Results showing identification of RPA amplicons after incubation for period of 40 min at 38 °C using PCRD nucleic acid detector: **a** NDV assay showed positive result; **b** IBV assay showed positive result; **c** negative control with negative result

Recombinase polymerase amplification reaction incubation at 38 °C for period of 20 min, followed by detecting the amplified amplicons using PCRD nucleic acid detector revealed in case of NDV, black lines at test line 1 (L1) and control line (C), while in the case of IBV assay and negative control revealed only black line at control line (C) (Fig. [3](#Fig3){ref-type="fig"}). The results indicated the LOD to be 10 genome copies (0.00001 ng) per RPA reaction using PCRD nucleic acid detector for both NDV and IBV assays (Fig. [4](#Fig4){ref-type="fig"}).Fig. 3Results showing identification of RPA amplicons after incubation for period of 20 min at 38 °C using PCRD nucleic acid detector: **a** Negative control; **b** IBV assay showed negative result; **c** NDV assay showed positive resultFig. 4The limit of detection (LOD) for both NDV (**a**) and IBV (**b**) assays, the NALF results present the LOD as 10 genome copies (0.00001 ng) per RPA reaction for both assays

Assays performance on clinical samples {#Sec11}
--------------------------------------

RT-RPA-NALF immunoassays and qRT-PCR were used to screen 12 pooled clinical samples for NDV and IBV (Fig. [5](#Fig5){ref-type="fig"}). NDV positive rate detection by qRT-PCR and RT-RPA-NALF was 66.7% (8/12) and 75% (8/12), respectively and 91.7% agreement was observed for the two methods with a kappa correlation of 0.792. IBV nucleic acid detected in 25% (3/12) and 16.7% (2/12) of the samples by qRT-PCR and RT-RPA-NALF, respectively, and the observed agreement was 91.7% with a kappa correlation of 0.750. All IBV positive samples showed mixed infection with NDV.Fig. 5Performance of RT-RPA-NALF assays on clinical samples for IBV and NDV detection: **a** Negative control; **b** positive controls (10^3^ genome copies per reaction) for IBV (left) and NDV (right) assays; **c** clinical samples showed negative (left) and positive (right) results for NDV; **d** clinical samples showed negative (left) and positive (right) results for IBV

Discussion {#Sec12}
==========

NDV and IBV can cause great economic losses for poultry industry in form of weight loss, decreased egg production and misshaped eggs, immunosuppression as well as vaccination and treatment costs \[[@CR22]--[@CR24]\]. Also, NDV has a minor zoonotic importance and can cause very mild and self-limiting conjunctivitis in human \[[@CR25]\].

Rapid and specific diagnosis of ND and IB diseases followed by application of control measures is required for monitoring and limiting the spread of NDV and IBV among chickens. Therefore, the objective of our study was developing simple, field applicable and rapid RPA-NALF immunoassays for NDV and IBV detection.

Herein, we used primers designed previously to identify M gene of NDV and N gene of IBV as these genes are highly conserved and suitable as targets for diagnosis of these diseases \[[@CR10], [@CR21]\].

The developed RPA assays for NDV and IBV were highly sensitive (10 genome copies detected/reaction) and rapid (less than 1 h). In case of NDV assay, the total time for detection could be 20 min only.

Several real-time RT-PCRs based tests have been reported for sensitive detection of NDV and IBV \[[@CR10], [@CR12], [@CR13], [@CR26]\]. However, they required more than 1 h for test result. Further, to prevent workplace or reagents contamination with amplified products, the master mix preparation, adding of the nucleic acids sample to the master mix and the amplification reaction must be carried out in separate clean benches. Moreover, reagents of real-time PCR must be kept at − 20 °C. Therefore, real-time PCR is unsuitable for pathogen detection on spot of infection.

Recombinase polymerase amplification reactions could be performed by simple hand held heating devices instead of using thermal cyclers as in case of conventional and real time PCR. Also, RPA reagents are cold chain independent making it more suitable rapid on site diagnosis \[[@CR27], [@CR28]\].

Recently, reverse transcription loop-mediated isothermal amplification (RT-LAMP) assays were described for molecular detection of NDV and IBV \[[@CR29], [@CR30]\]. In contrast to RPA, LAMP reactions use six primers, which are difficult to design in viruses showing high mutation rate like NDV and IBV.

Lateral flow immunoassays (LFIAs) are currently used for pathogen detection depending on antigen or antibody detection under field condition because they are inexpensive, rapid, simple and disposable but with some difficulties to get results with high specificity and sensitivity. Different microfluidic systems were designed for nucleic acid amplification and detection on-chip \[[@CR31], [@CR32]\]. However, most of these microfluidic systems use a syringe pump to operate, as well as additional imaging instrumentation to acquire test results. Additionally, NALF can improve the sensitivity and specificity of LFIAs through signaling amplification \[[@CR33]\]. The combination of RPA with a lateral flow assay device gives substantial advantage over PCR-based assays especially in laboratories with limited resources.

The limit of detection is one of the factors that determine the sensitivity of any molecular test. The results reveal a LOD of 10 genome copies per RPA reaction for both NDV and IBV assays after incubation for 40 min at 38 °C.

Typically, commercial chickens are vaccinated during their production cycle to prevent NDV and IBV infections. Live vaccines can persist in the farm for long period during the production cycle. Thus, such assays (targeting a conservative region of the viruses genome) could be useful as a preliminary screening test (positive/negative result). We evaluated our assays performance using 12 pooled clinical samples. The results of RT-RPA-NALF revealed good performance in comparison with qRT-PCR in both sensitivity and specificity. Further studies should be directed toward testing the clinical sensitivity using a larger number of clinical specimens.

Further studies are crucial to improve the assays to be able to distinguish field virulent virus strains from vaccine strains which needed to choose appropriate control measures. Also, a simple and field applicable method to extract pathogens' nucleic acids will greatly facilitate using RPA-NALF assays for on-site diagnosis \[[@CR34]\].

In addition to the promising results of our current study, the developed assay could be further improved while the current RPA-NALF test detects NDV and IBV in two separate assays, both assays could be combined in a single test. Accordingly, designing primers and validated RPA conditions capable of identifying mixed infection simultaneously using single assay are crucial.

In conclusion, RPA-NALF tests demonstrated in this study can facilitate rapid, on-site molecular diagnosis of suspected cases of ND and IB diseases as the results can be detected by the naked eye without the need for measuring fluorescence. Furthermore, the NALF device could be adapted to detect other infectious agents.
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